Data from Pharmawand - Curated by EPG Health - Date added 23 October 2013

NeuroAiD, from Moleac, reduces early cardiovascular events and deaths by nearly 50% on top of antiplatelet agents within three months in patients after Stroke onset, without an increase in bleeding rate and non-vascular deaths according to research published in the journal Stroke. The CHIMES study is an international double-blind placebo-controlled clinical trial in 1099 patients having suffered an ischemic stroke of intermediate severity within 72 hours, treated by NeuroAiD or placebo and monitored for 3 months.

NeuroAiD may have an effect on preventing the occurrence of early vascular events after stroke onset: the vascular outcome occurred in 16 patients (2.9%) of the NeuroAiD group, as opposed to 31 patients (5.6%) in the placebo group. This represents half the rate of early cardiovascular events and deaths, which corresponds to about 27 fewer patients suffering a recurrent vascular event or death per 1000 patients treated over 3 months. Patients on NeuroAiD having fewer adverse events than those in the placebo group. See: "Effects of MLC601 on Early Vascular Events in Patients After Stroke: The CHIMES Study." Chen CLH et al. Stroke 2013; 44 October 17, 2013. doi: 10.1161/STROKEAHA.113.003226

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

ESICM LIVES Highlights

ESICM LIVES Highlights

ESICM LIVES Congress 2018: Bringing you the latest news and insights from the 31st ESICM LIVES Congress, 20–24 October 2018 Paris, France.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Cardiovascular Metabolism Knowledge Centre

Cardiovascular Metabolism Knowledge Centre

The Cardiovascular Metabolism Knowledge Centre is an information hub providing expert insight into the management of hypertension and type 2 diabetes. This Knowledge Centre contains a wealth of scientific video content offering insights and opinion from some of the leading experts in the field.

Load more

Related Content